Distinct domain switching in Nd0.05Ce0.95CoIn5 at low and high fields

QR Code

Distinct domain switching in Nd0.05Ce0.95CoIn5 at low and high fields

Abstract Nd0.05Ce0.95CoIn5 features a magnetic field-driven quantum phase transition that separates two antiferromagnetic phases with an identical magnetic structure inside the superconducting condensate. Using neutron diffraction we demonstrate that the population of the two magnetic domains in the...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. G. Mazzone, R. Yadav, M. Bartkowiak, J. L. Gavilano, S. Raymond, E. Ressouche, G. Lapertot, M. Kenzelmann
Format:	article
Language:	EN
Published:	Nature Portfolio 2018
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/844fe8cc5bf84e9b8f3d95b2d4fd04ca
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

One-Pot Synthesis of Ni<sub>0.05</sub>Ce<sub>0.95</sub>O<sub>2−δ</sub> Catalysts with Nanocubes and Nanorods Morphology for CO<sub>2</sub> Methanation Reaction and in Operando DRIFT Analysis of Intermediate Species
by: Igor Luisetto, et al.
Published: (2021)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
by: Inoue K, et al.
Published: (2012)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
by: Kanamoto T, et al.
Published: (2012)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
by: Mizoguchi T, et al.
Published: (2017)

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
by: Turan-Vural E, et al.
Published: (2011)

Evolution of two bulk-superconducting phases in Sr0.5 RE 0.5FBiS2 (RE: La, Ce, Pr, Nd, Sm) by external hydrostatic pressure effect
by: Aichi Yamashita, et al.
Published: (2020)

Facile synthesis of g-C3N4(0.94)/CeO2(0.05)/Fe3O4(0.01) nanosheets for DFT supported visible photocatalysis of 2-Chlorophenol
by: Jamshaid Rashid, et al.
Published: (2019)

Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
by: Yelda Buyru &Ouml;zkurt, et al.
Published: (2009)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
by: Douglas J Rhee, et al.
Published: (2008)

Green synthesis, characterization and anti-cancer capability of Co0.5Ni0.5Nd0.02Fe1.98O4 nanocomposites
by: M.A. Almessiere, et al.
Published: (2022)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
by: Inoue K, et al.
Published: (2014)

The Bayes Factor, a Suitable Complement beyond Values of p<0.05 in Nursing Research and Education
by: Cristian Antony Ramos-Vera
Published: (2021)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
by: Deveney T, et al.
Published: (2018)

LiNi0.8Co0.15Al0.05O2: Enhanced Electrochemical Performance From Reduced Cationic Disordering in Li Slab
by: Peng Xiao, et al.
Published: (2017)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
by: Arthur B Epstein, et al.
Published: (2009)

Impacto sobre el tamaño de las muestras en estudios nacionales si cambiara el nivel de significación estadística de α= 0,05 a α = 0,005
by: Villarroel del Pino,Luis
Published: (2021)

Crystal structure, thermal and electrotransport properties of NdBa1–xSrxFeCo0.5Cu0.5O5+δ (0.02 ≤ x ≤ 0.20) solid solutions
by: A. I. Klyndyuk, et al.
Published: (2021)

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial
by: Palacio-Pastrana C, et al.
Published: (2020)

Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
by: Alfredo Rossi, et al.
Published: (2020)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
by: Inoue K, et al.
Published: (2012)

Impact of dielectric properties on ionic conductivity of Ce0.9Sm0.1O1.95 via defect interaction
by: Sk. Anirban, et al.
Published: (2021)

Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)
by: Katelin Quantz, et al.
Published: (2021)

Efficacy and safety of 0.5% levobupivacaine versus 0.5% bupivacaine for peribulbar anesthesia
by: Pacella E, et al.
Published: (2013)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
by: Burade V, et al.
Published: (2020)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015)

A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
by: Kusne Y, et al.
Published: (2016)

Li(V0.5Ti0.5)S2 as a 1 V lithium intercalation electrode
by: Steve J. Clark, et al.
Published: (2016)

Influence of LRE (Ce, Y, and La) on microstructure and magnetic properties of (Nd0.8LRE0.2)–Fe–B hot-deformed magnets
by: Y. Milov, et al.
Published: (2021)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
by: Rhee MK, et al.
Published: (2017)

Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
by: William Stringer, et al.
Published: (2010)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
by: Schnober D, et al.
Published: (2015)

Preparation and characterization of a new graphite superconductor: Ca0.5Sr0.5C6
by: Saki Nishiyama, et al.
Published: (2017)

Light-induced enhancement of superconductivity in iron-based superconductor FeSe0.5Te0.5
by: Kazuki Isoyama, et al.
Published: (2021)

Magnetic breakdown in 2D hole system at GaAs/Al0.5Ga0.5As heterointerface
by: Minina, N., et al.
Published: (2005)

Photoconductivity in p-GaAs/Al0.5Ga0.5As and deep donor like states at heterointerface
by: Bogdanov, E., et al.
Published: (2005)

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
by: Stonecipher KG, et al.
Published: (2016)

Difluprednate ophthalmic emulsion 0.05% (Durezol&reg;) administered two times daily for managing ocular inflammation and pain following cataract surgery
by: Stephen Smith, et al.
Published: (2010)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
by: Mizoguchi T, et al.
Published: (2012)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
by: Baiza-Dur&aacute;n LM, et al.
Published: (2012)

Thick Film Ni0.5Mn0.5−xSnx Heusler Alloys by Multi-layer Electrochemical Deposition
by: Yijia Zhang, et al.
Published: (2018)